Pages that link to "Q27469644"
Jump to navigation
Jump to search
The following pages link to Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3 (Q27469644):
Displaying 50 items.
- Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse (Q21144516) (← links)
- Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers (Q24520621) (← links)
- Stereophysicochemical variability plots highlight conserved antigenic areas in Flaviviruses (Q24804265) (← links)
- West Nile Virus Temperature Sensitivity and Avian Virulence Are Modulated by NS1-2B Polymorphisms (Q26513109) (← links)
- Dengue virus 1 in Buenos Aires from 1999 to 2010: towards local spread (Q27334332) (← links)
- Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine (Q27469646) (← links)
- Chimeric Dengue 2 PDK-53/West Nile NY99 Viruses Retain the Phenotypic Attenuation Markers of the Candidate PDK-53 Vaccine Virus and Protect Mice against Lethal Challenge with West Nile Virus (Q27469831) (← links)
- Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice (Q27469872) (← links)
- Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone (Q27469879) (← links)
- Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine (Q27469921) (← links)
- Infectious cDNA clone of the epidemic west nile virus from New York City (Q27472878) (← links)
- A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys (Q27473080) (← links)
- Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model (Q27473317) (← links)
- American Genotype Structures Decrease Dengue Virus Output from Human Monocytes and Dendritic Cells (Q27473379) (← links)
- Characterization of a small plaque variant of West Nile virus isolated in New York in 2000 (Q27485096) (← links)
- Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development (Q27485759) (← links)
- Neuroadapted Yellow Fever Virus 17D: Determinants in the Envelope Protein Govern Neuroinvasiveness for SCID Mice (Q27486896) (← links)
- Identification of genetic determinants of a tick-borne flavivirus associated with host-specific adaptation and pathogenicity (Q27487383) (← links)
- Structural and Functional Studies of the Promoter Element for Dengue Virus RNA Replication (Q27487528) (← links)
- Characterization of Recombinant Dengue-2 Virus Derived from a Single Nucleotide Substitution in the 5′ Noncoding Region (Q27491304) (← links)
- Dengue structure differs at the temperatures of its human and mosquito hosts (Q27677270) (← links)
- Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis (Q28237906) (← links)
- A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates (Q28241909) (← links)
- A Reverse Genetics Platform That Spans the Zika Virus Family Tree (Q28954816) (← links)
- Prospects for a dengue virus vaccine (Q29619608) (← links)
- The 5' and 3' Untranslated Regions of the Flaviviral Genome (Q32183359) (← links)
- Dengue vaccines: state of the art. (Q34109652) (← links)
- Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever (Q34202440) (← links)
- Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax). (Q34759091) (← links)
- Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus. (Q34787775) (← links)
- Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques (Q35031833) (← links)
- Traditional and novel approaches to flavivirus vaccines (Q35143285) (← links)
- Patterns of epistasis in RNA viruses: a review of the evidence from vaccine design (Q35593849) (← links)
- Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis (Q35625041) (← links)
- Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture (Q35645969) (← links)
- Dengue vaccine: priorities and progress (Q35964754) (← links)
- Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial (Q36024479) (← links)
- Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication (Q36092279) (← links)
- CD8 T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate (Q36208591) (← links)
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study (Q36288109) (← links)
- A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity (Q36813821) (← links)
- Molecular determinants of plaque size as an indicator of dengue virus attenuation (Q36906525) (← links)
- A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates (Q37336762) (← links)
- The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker (Q38092510) (← links)
- Challenges in reducing dengue burden; diagnostics, control measures and vaccines (Q38140035) (← links)
- Developing a dengue vaccine: progress and future challenges (Q38201151) (← links)
- Trials and tribulations on the path to developing a dengue vaccine (Q38540058) (← links)
- Development of a recombinant, chimeric tetravalent dengue vaccine candidate (Q38639091) (← links)
- A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone (Q38658737) (← links)
- Isolation and characterization of dengue virus serotype 2 from the large dengue outbreak in Guangdong, China in 2014. (Q39077054) (← links)